Wall Street giant Goldman Sachs has emerged as the lead market maker of the $34 million Capital Group US Large Growth ETF.

On Tuesday, the S&P 500 closed down 0.3%, snapping a remarkable streak of six straight closing highs through Monday.

The company, mired in too many scandals and setbacks to print, lost nearly $12 billion when all was said and done in 2024.

Staffing shortages, rising prescription drug use, and costly new therapies have driven inflation in the medical sector.

The faith-based ETF segment focuses less on generating alpha and more on adhering to religious principles and values.